And in the fourth simulation (fourth row in Fig. 6e), we modeled the combination of GVAX, Checkpoint, and CD137 agonist, which in our model resulted in effective tumor clearance through effective infiltration and killing (Fig. 6c). This evidence concerns the gene TNFRSF9 and neoplasm.